Related references
Note: Only part of the references are listed.The ibogaine medical subculture
Kenneth R. Alper et al.
JOURNAL OF ETHNOPHARMACOLOGY (2008)
β2 subunit containing acetylcholine receptors mediate nicotine withdrawal deficits in the acquisition of contextual fear conditioning
George S. Portugal et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2008)
Decreased withdrawal symptoms but normal tolerance to nicotine in mice null for the α7 nicotinic acetylcholine receptor subunit
Ramiro Salas et al.
NEUROPHARMACOLOGY (2007)
Exposure to nicotine and sensitization of nicotine-induced behaviors
P. Vezina et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Bupropion inhibits the cellular effects of nicotine in the ventral tegmental area
Huibert D. Mansvelder et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Stress, dysregulation of drug reward pathways, and the transition to drug dependence
George Koob et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
18-MC acts in the medial habenula and interpeduncular nucleus to attenuate dopamine sensitization to morphine in the nucleus accumbens
Olga D. Taraschenko et al.
SYNAPSE (2007)
Rationale, pharmacology and clinical efficacy of partial agonists of α4β2 nACh receptors for smoking cessation
Hans Rollema et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Lateral habenula as a source of negative reward signals in dopamine neurons
Masayuki Matsumoto et al.
NATURE (2007)
Depression predicts smoking early but not late in a quit attempt
Sandra J. Japuntich et al.
NICOTINE & TOBACCO RESEARCH (2007)
Cellular localization of mGluR3 and mGluR5 mRNAs in normal and injured rat brain
Giuseppa Mudo et al.
BRAIN RESEARCH (2007)
Decreased anxiety-like behavior in beta3 nicotinic receptor subunit knockout mice
T. K. Booker et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2007)
Nicotine gates long-term potentiation in the hippocampal CA1 region via the activation of α2*nicotinic ACh receptors
Sakura Nakauchi et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid
H. Rollema et al.
NEUROPHARMACOLOGY (2007)
Metabotropic glutamate receptor antagonists: Novel therapeutics for nicotine dependence and depression?
Athina Markou
BIOLOGICAL PSYCHIATRY (2007)
Non-nicotinic therapies for smoking cessation
Eric C. K. Siu et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2007)
Animal models and treatments for addiction and depression co-morbidity
Neil E. Paterson et al.
NEUROTOXICITY RESEARCH (2007)
Anxiety, anxiety disorders, tobacco use, and nicotine: A critical review of interrelationships
Sandra Baker Morissette et al.
PSYCHOLOGICAL BULLETIN (2007)
Effects of abstinence from tobacco: Valid symptoms and time course
John R. Hughes
NICOTINE & TOBACCO RESEARCH (2007)
Varenicline is a partial agonist at α4β2 and a full agonist at α7 neuronal nicotinic receptors
Karla B. Mihalak et al.
MOLECULAR PHARMACOLOGY (2006)
Cytisine for smoking cessation - A literature review and a meta-analysis
Jean-Francois Etter
ARCHIVES OF INTERNAL MEDICINE (2006)
Genetic dissociation of two behaviors associated with nicotine addiction: Beta-2 containing nicotinic receptors are involved in nicotine reinforcement but not in withdrawal syndrome
M. Besson et al.
PSYCHOPHARMACOLOGY (2006)
Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation -: A randomized controlled trial
Douglas E. Jorenby et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Involvement of the endocannabinoid system in drug addiction
R Maldonado et al.
TRENDS IN NEUROSCIENCES (2006)
Bupropion attenuates nicotine abstinence syndrome in the rat
DH Malin et al.
PSYCHOPHARMACOLOGY (2006)
Rimonabant for overweight or obesity
C. Curioni et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2006)
Comparison of α2 nicotinic acetylcholine receptor subunit mRNA expression in the central nervous system of rats and mice
K Ishii et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2005)
Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice
JA Davis et al.
JOURNAL OF NEUROSCIENCE (2005)
Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats
K Guillem et al.
JOURNAL OF NEUROSCIENCE (2005)
The neural basis of addiction: A pathology of motivation and choice
PW Kalivas et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors
U Maskos et al.
NATURE (2005)
Desensitization of nicotinic ACh receptors: shaping cholinergic signaling
R Giniatullin et al.
TRENDS IN NEUROSCIENCES (2005)
In pursuit of α4β2 nicotinic receptor partial agonists for smoking cessation:: Carbon analogs of (-)-cytisine
JW Coe et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Nicotine physical dependence in the mouse:: Involvement of the α7 nicotinic receptor subtype
SD Grabus et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene
F Berrendero et al.
JOURNAL OF NEUROSCIENCE (2005)
Nicotine dependence, depression, and gender: Characterizing phenotypes based on withdrawal discomfort, response to smoking, and ability to abstain
OF Pomerleau et al.
NICOTINE & TOBACCO RESEARCH (2005)
Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats
AY Bespalov et al.
NEUROPHARMACOLOGY (2005)
The ups and downs of addiction: role of metabotropic glutamate receptors
PJ Kenny et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study
AL Brody et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2004)
Alpha bungarotoxin-1.4 nm gold: a novel conjugate for visualising the precise subcellular distribution of alpha 7*nicotinic acetylcholine receptors
IW Jones et al.
JOURNAL OF NEUROSCIENCE METHODS (2004)
Neuronal and astrocyte expression of nicotinic receptor subunit β4 in the adult mouse brain
LC Gahring et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2004)
Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences
B Le Foll et al.
NEUROREPORT (2004)
Bupropion for smoking cessation - A randomized trial
JA Simon et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
The α3 and β4 nicotinic acetylcholine receptor subunits are necessary for nicotine-induced seizures and hypolocomotion in mice
R Salas et al.
NEUROPHARMACOLOGY (2004)
Shape of the relapse curve and long-term abstinence among untreated smokers
JR Hughes et al.
ADDICTION (2004)
Brain substrates for increased drug seeking during protracted withdrawal
G Aston-Jones et al.
NEUROPHARMACOLOGY (2004)
Decreased signs of nicotine withdrawal in mice null for the β4 nicotinic acetylcholine receptor subunit
R Salas et al.
JOURNAL OF NEUROSCIENCE (2004)
Nicotine activation of α4*receptors:: Sufficient for reward, tolerance, and sensitization
AR Tapper et al.
SCIENCE (2004)
Neuroadaptive changes in the mesoaccumbens dopamine system after chronic nicotine self-administration: A microdialysis study
S Rahman et al.
NEUROSCIENCE (2004)
Extinguishing the rewarding value of smoke cues: Pharmacological and behavioral treatments
JE Rose et al.
NICOTINE & TOBACCO RESEARCH (2004)
Nicotinic acetylcholine receptors and the regulation of neuronal signalling
F Dajas-Bailador et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Characterization of spontaneous and precipitated nicotine withdrawal in the mouse
MI Damaj et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats
AW Bruijnzeel et al.
SYNAPSE (2003)
Transient behavioral sensitization to nicotine becomes long-lasting with monoamine oxidases inhibitors
AS Villégier et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2003)
Group II metabotropic and α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats
PJ Kenny et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Effect of bupropion on nicotine self-administration in rats
AS Rauhut et al.
PSYCHOPHARMACOLOGY (2003)
Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat
JF Cryan et al.
PSYCHOPHARMACOLOGY (2003)
Anti-addictive actions of an iboga alkaloid congener:: a novel mechanism for a novel treatment
IM Maisonneuve et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2003)
Prolonged activation of mesolimbic dopaminergic neurons by morphine withdrawal following clonidine: Participation of imidazoline and norepinephrine receptors
F Georges et al.
NEUROPSYCHOPHARMACOLOGY (2003)
The nicotinic acetylcholine receptor subunit α5 mediates short-term effects of nicotine in vivo
R Salas et al.
MOLECULAR PHARMACOLOGY (2003)
The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice
NE Paterson et al.
PSYCHOPHARMACOLOGY (2003)
Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors
LM Marubio et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Smoking withdrawal dynamics: III. Correlates of withdrawal heterogeneity
TM Piasecki et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2003)
Desensitization of neuronal nicotinic receptors
MW Quick et al.
JOURNAL OF NEUROBIOLOGY (2002)
Reboxetine: Attenuation of intravenous nicotine self-administration in rats
AS Rauhut et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Modulation of nicotine self-administration in rats by combination therapy with agents blocking α3β4 nicotinic receptors
SD Glick et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Autonomic function in mice lacking α5 neuronal nicotinic acetylcholine receptor subunit
N Wang et al.
JOURNAL OF PHYSIOLOGY-LONDON (2002)
Upregulation of neuronal nicotinic receptor subunits α4, β2, and α7 in transgenic mice overexpressing human acetylcholinesterase
MM Svedberg et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2002)
Psychophysiological effects of nicotine abstinence and behavioral challenges in habitual smokers
M al'Absi et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
Absence of α7-containing neuronal nicotinic acetylcholine receptors does not prevent nicotine-induced seizures
D Franceschini et al.
MOLECULAR BRAIN RESEARCH (2002)
Increased sensitivity to nicotine-induced seizures in mice expressing the L250T alpha 7 nicotinic acetylcholine receptor mutation
RS Broide et al.
MOLECULAR PHARMACOLOGY (2002)
Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine
E Valjent et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
How does stress increase risk of drug abuse and relapse?
R Sinha
PSYCHOPHARMACOLOGY (2001)
Neurobiology of the nicotine withdrawal syndrome
PJ Kenny et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2001)
Anxiety sensitivity - Relationship to negative affect smoking and smoking cessation in smokers with past major depressive disorder
RA Brown et al.
ADDICTIVE BEHAVIORS (2001)
Effects of nicotine and mecamylamine-induced withdrawal on extracellular dopamine and acetylcholine in the rat nucleus accumbens
P Rada et al.
PSYCHOPHARMACOLOGY (2001)
Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats
AA Harrison et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Self-reported abstinence effects in the first month after smoking cessation
MM Ward et al.
ADDICTIVE BEHAVIORS (2001)
The dorsal raphe nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses
S Cheeta et al.
PSYCHOPHARMACOLOGY (2001)
α10:: A determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells
AB Elgoyhen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Drug addiction, dysregulation of reward, and allostasis
GF Koob et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Tolerance to nicotine's effects in the elevated plus-maze and increased anxiety during withdrawal
EE Irvine et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2001)
Augmented accumbal serotonin levels decrease the preference for a morphine associated environment during withdrawal
GC Harris et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Single-neuron responses to emotional visual stimuli recorded in human ventral prefrontal cortex
H Kawasaki et al.
NATURE NEUROSCIENCE (2001)
Long-term potentiation of excitatory inputs to brain reward areas by nicotine
HD Mansvelder et al.
NEURON (2000)
Effects of chronic oral nicotine treatment and its withdrawal on locomotor activity and brain monoamines in mice
H Gäddnäs et al.
BEHAVIOURAL BRAIN RESEARCH (2000)
Short-term weight gain in abstaining women smokers
CS Pomerleau et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2000)
Prefrontal dopamine is directly involved in the anxiogenic interoceptive cue of pentylenetetrazol but not in the interoceptive cue of chlordiazepoxide in the rat
LM Broersen et al.
PSYCHOPHARMACOLOGY (2000)
Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats
E Carboni et al.
DRUG AND ALCOHOL DEPENDENCE (2000)
Tobacco withdrawal in women and menstrual cycle phase
KA Perkins et al.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY (2000)
Nicotinic acetylcholine receptor subunit mRNA expression and channel function in medial habenula neurons
EB Sheffield et al.
NEUROPHARMACOLOGY (2000)
Share Paper
